Plasma biomarker profiles in autosomal dominant Alzheimer’s disease is a research paper published in Brain (2023). On theSindex it has a DataRank of 0. It has been cited 73 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Swedish Research Council
Grant: #2018-02532
European Research Council
Grant: #681712
Swedish State Support for Clinical Research
Grant: #ALFGBG-720931
Alzheimer's Drug Discovery Foundation
Grant: #201809-2016862
Alzheimer's Association
Grant: #ADSF-21-831376-C
Alzheimer's Association
Grant: #ADSF-21-831381-C
Alzheimer's Association
Grant: #ADSF-21-831377-C
Hjärnfonden, Sweden
Grant: #FO2019-0228
European Union’s Horizon 2020
Grant: 860197
European Union’s Horizon 2020
Grant: #2017-00915
European Union’s Horizon 2020
Grant: #RDAPB-201809-2016615
Swedish Alzheimer Foundation
Grant: #AF-930351
Swedish Alzheimer Foundation
Grant: #AF-939721
Swedish Alzheimer Foundation
Grant: #AF-968270
Swedish Alzheimer Foundation
Grant: #FO2017-0243
Swedish Alzheimer Foundation
Grant: #ALZ2022-0006
ALF-agreement
Grant: #ALFGBG-715986
ALF-agreement
Grant: #ALFGBG-965240
European Union Joint Program for Neurodegenerative Disorders
Grant: JPND2019-466-236
National Institutes of Health
Grant: #1R01AG068398-01
Alzheimer’s Association 2021 Zenith
Grant: ZEN-21-848495
Alzheimer’s Association 2021 Zenith
Grant: #529-2014-7504
Alzheimer’s Association 2021 Zenith
Grant: #2015-02926
Alzheimer’s Association 2021 Zenith
Grant: #2018-02754
European Research Council
Grant: 681712
Medical Research Council
Grant: UKDRI-1003
European Research Council
Grant: 720931
NIA NIH HHS
Grant: R01 AG068398
Gun and Bertil Stohne’s Foundation
Olav Thon Foundation
Swedish Dementia Foundation
Swedish Brain Foundation
ALF Medicine
Stiftelsen för Gamla Tjänarinnor
AD Strategic Fund
Erling-Persson Family Foundation
FWCI
10.30
Citation Percentile
1.0%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer’s disease-associated biomarkers alterations among de novo Parkinson’s disease patients: a prospective cohort study
Additional file 1 of Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer’s disease-associated biomarkers alterations among de novo Parkinson’s disease patients: a prospective cohort study
Additional file 1 of Altered plasma protein profiles in genetic FTD – a GENFI study
Additional file 1 of Altered plasma protein profiles in genetic FTD – a GENFI study
Additional file 1 of Gene-variant specific effects of plasma amyloid-β levels in Swedish autosomal dominant Alzheimer disease
Additional file 1 of Gene-variant specific effects of plasma amyloid-β levels in Swedish autosomal dominant Alzheimer disease